Stone Summit Wealth’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Stone Summit Wealth's LLY Position: Q2 2026 in Review
Stone Summit Wealth increased its Eli Lilly (LLY) stake by 2.7% in Q2 2026, buying an estimated $92K and bringing the position to 3,470 shares worth $4.16M. The position accounts for 1.06% of the portfolio, ranked #32.
Stone Summit Wealth first reported a position in LLY in Q1 2022 and has held it in 18 quarters since. 4,624 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Stone Summit Wealth held 3,470 shares of Eli Lilly worth $4.16M as of Q2 2026.
- Stone Summit Wealth bought 90 Eli Lilly shares in Q2 2026, an estimated $92K.
- Eli Lilly made up 1.06% of Stone Summit Wealth's portfolio in Q2 2026, its #32 holding.
- Stone Summit Wealth first reported a position in Eli Lilly in Q1 2022 and has held it in 18 quarters since.
- 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Stone Summit Wealth's 13F filing for Q2 2026, filed 23 Jul 2026.